117 related articles for article (PubMed ID: 38151384)
1. Ability change across multiple domains in mucopolysaccharidosis (Sanfilippo syndrome) type IIIA.
Shapiro EG; Eisengart JB; Whiteman D; Whitley CB
Mol Genet Metab; 2024 Feb; 141(2):108110. PubMed ID: 38151384
[TBL] [Abstract][Full Text] [Related]
2. An observational, prospective, multicenter, natural history study of patients with mucopolysaccharidosis type IIIA.
Wijburg FA; Aiach K; Chakrapani A; Eisengart JB; Giugliani R; Héron B; Muschol N; O'Neill C; Olivier S; Parker S
Mol Genet Metab; 2022 Feb; 135(2):133-142. PubMed ID: 34991944
[TBL] [Abstract][Full Text] [Related]
3. A prospective one-year natural history study of mucopolysaccharidosis types IIIA and IIIB: Implications for clinical trial design.
Truxal KV; Fu H; McCarty DM; McNally KA; Kunkler KL; Zumberge NA; Martin L; Aylward SC; Alfano LN; Berry KM; Lowes LP; Corridore M; McKee C; McBride KL; Flanigan KM
Mol Genet Metab; 2016 Nov; 119(3):239-248. PubMed ID: 27590925
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal MRI brain volume changes over one year in children with mucopolysaccharidosis types IIIA and IIIB.
Abreu NJ; Selvaraj B; Truxal KV; Moore-Clingenpeel M; Zumberge NA; McNally KA; McBride KL; Ho ML; Flanigan KM
Mol Genet Metab; 2021 Jun; 133(2):193-200. PubMed ID: 33962822
[TBL] [Abstract][Full Text] [Related]
5. Analysis of cognitive ability and adaptive behavior assessment tools used in an observational study of patients with mucopolysaccharidosis II.
Yee KS; Wu Y; Harrington M; Waisbren SE
Orphanet J Rare Dis; 2021 Dec; 16(1):501. PubMed ID: 34863240
[TBL] [Abstract][Full Text] [Related]
6. Hematopoietic stem cell transplantation in mucopolysaccharidosis type IIIA: A case description and comparison with a genotype-matched control group.
Köhn AF; Grigull L; du Moulin M; Kabisch S; Ammer L; Rudolph C; Muschol NM
Mol Genet Metab Rep; 2020 Jun; 23():100578. PubMed ID: 32226768
[TBL] [Abstract][Full Text] [Related]
7. Long-term safety and clinical outcomes of intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A.
Wijburg FA; Heap F; Rust S; de Ruijter J; Tump E; Marchal JP; Nestrasil I; Shapiro E; Jones SA; Alexanderian D
Mol Genet Metab; 2021 Dec; 134(4):317-322. PubMed ID: 34600820
[TBL] [Abstract][Full Text] [Related]
8. A multicenter open-label extension study of intrathecal heparan-N-sulfatase in patients with Sanfilippo syndrome type A.
Wijburg FA; Whitley CB; Muenzer J; Gasperini S; Del Toro M; Muschol N; Cleary M; Sevin C; Shapiro E; Alexanderian D
Mol Genet Metab; 2021; 134(1-2):175-181. PubMed ID: 34247932
[TBL] [Abstract][Full Text] [Related]
9. Neurodevelopmental status and adaptive behavior of pediatric patients with mucopolysaccharidosis II: a longitudinal observational study.
Muenzer J; Burton BK; Amartino HM; Harmatz PR; Gutiérrez-Solana LG; Ruiz-Garcia M; Wu Y; Merberg D; Alexanderian D; Jones SA
Orphanet J Rare Dis; 2023 Nov; 18(1):357. PubMed ID: 37974184
[TBL] [Abstract][Full Text] [Related]
10. Developmental outcomes of children with congenital diaphragmatic hernia: a multicenter prospective study.
Wynn J; Aspelund G; Zygmunt A; Stolar CJ; Mychaliska G; Butcher J; Lim FY; Gratton T; Potoka D; Brennan K; Azarow K; Jackson B; Needelman H; Crombleholme T; Zhang Y; Duong J; Arkovitz MS; Chung WK; Farkouh C
J Pediatr Surg; 2013 Oct; 48(10):1995-2004. PubMed ID: 24094947
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. An open-label pilot trial of minocycline in children as a treatment for Angelman syndrome.
Grieco JC; Ciarlone SL; Gieron-Korthals M; Schoenberg MR; Smith AG; Philpot RM; Heussler HS; Banko JL; Weeber EJ
BMC Neurol; 2014 Dec; 14():232. PubMed ID: 25491305
[TBL] [Abstract][Full Text] [Related]
13. Increasing precision in the measurement of change in pediatric neurodegenerative disease.
Eisengart JB; Daniel MH; Adams HR; Williams P; Kuca B; Shapiro E
Mol Genet Metab; 2022; 137(1-2):201-209. PubMed ID: 36115283
[TBL] [Abstract][Full Text] [Related]
14. The natural history of neurocognition in MPS disorders: A review.
Shapiro EG; Eisengart JB
Mol Genet Metab; 2021 May; 133(1):8-34. PubMed ID: 33741271
[TBL] [Abstract][Full Text] [Related]
15. Quantifying medical manifestations in Hurler syndrome with the infant physical symptom score: associations with long-term physical and adaptive outcomes.
Ahmed A; Rudser K; King KE; Eisengart JB; Orchard PJ; Shapiro E; Whitley CB
Mol Genet Metab; 2022 May; 136(1):22-27. PubMed ID: 35304037
[TBL] [Abstract][Full Text] [Related]
16. Vineland Adaptive Behavior Scale in a Cohort of Four ADNP Syndrome Patients Implicates Age-Dependent Developmental Delays with Increased Impact of Activities of Daily Living.
Levine J; Hakim F; Kooy RF; Gozes I
J Mol Neurosci; 2022 Aug; 72(8):1531-1546. PubMed ID: 35920977
[TBL] [Abstract][Full Text] [Related]
17. Interim results of adaptive functioning and neurodevelopment in BUTTERFLY - An observational study of children and adolescents with Dravet syndrome.
Sullivan J; Wirrell E; Knupp KG; Chen D; Zafar M; Flamini R; Stutely J; Brathwaite C; Ventola P; Avendaño J; Parkerson KA; Wyant N; Ticho B
Epilepsy Behav; 2022 Dec; 137(Pt A):108955. PubMed ID: 36332561
[TBL] [Abstract][Full Text] [Related]
18. A neurodevelopmental survey of Angelman syndrome with genotype-phenotype correlations.
Gentile JK; Tan WH; Horowitz LT; Bacino CA; Skinner SA; Barbieri-Welge R; Bauer-Carlin A; Beaudet AL; Bichell TJ; Lee HS; Sahoo T; Waisbren SE; Bird LM; Peters SU
J Dev Behav Pediatr; 2010 Sep; 31(7):592-601. PubMed ID: 20729760
[TBL] [Abstract][Full Text] [Related]
19. A Prospective Natural History Study of Mucopolysaccharidosis Type IIIA.
Shapiro EG; Nestrasil I; Delaney KA; Rudser K; Kovac V; Nair N; Richard CW; Haslett P; Whitley CB
J Pediatr; 2016 Mar; 170():278-87.e1-4. PubMed ID: 26787381
[TBL] [Abstract][Full Text] [Related]
20. Vineland adaptive behavior scales to identify neurodevelopmental problems in children with Congenital Hyperinsulinism (CHI).
Salomon-Estebanez M; Mohamed Z; Michaelidou M; Collins H; Rigby L; Skae M; Padidela R; Rust S; Dunne M; Cosgrove K; Banerjee I; Nicholson J
Orphanet J Rare Dis; 2017 May; 12(1):96. PubMed ID: 28532504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
